CD9-binding peptide (TFA)
CD9-binding peptide TFA is a CD9-binding peptide. CD9-binding peptide TFA inhibits the binding of EWI-2 to CD9. CD9-binding peptide TFA exhibits selective anti-migratory and anti-invasive activities against cancer cells. CD9-binding peptide TFA can be used for the study of cancer[1].
Product Specifications
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Cancer
Purity
99.02
Smiles
OC([C@H](CC1=CN=CN1)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CO)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F.[x]
Molecular Formula
C45H79N21O10.xC2HF3O2
Molecular Weight
1074.24 (free base)
References & Citations
[1]Suwatthanarak T, et al. Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide. Chem Commun (Camb) . 2021 May 18;57 (40) :4906-4909.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
